Discounted Cash Flow (DCF) Analysis Unlevered

Walgreens Boots Alliance, Inc. (WBA)

$20.91

-0.11 (-0.52%)
All numbers are in Millions, Currency in USD
Stock DCF: 251.14 | 20.91 | undervalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 131,537136,866139,537132,509132,703133,072.12133,442.27133,813.45134,185.66134,558.90
Revenue (%)
EBITDA 8,3617,2693,3095,4546,3756,110.346,127.336,144.386,161.476,178.61
EBITDA (%)
EBIT 6,5915,2311,3823,4814,3854,192.984,204.644,216.334,228.064,239.82
EBIT (%)
Depreciation 1,7702,0381,9271,9731,9901,917.361,922.691,928.041,933.401,938.78
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 7851,0235161,1932,4721,191.571,194.881,198.211,201.541,204.88
Total Cash (%)
Account Receivables 6,5737,2267,1325,6635,0176,2396,256.356,273.766,291.216,308.71
Account Receivables (%)
Inventories 9,5659,3339,4518,1598,3538,866.798,891.458,916.198,940.998,965.86
Inventories (%)
Accounts Payable 13,56614,34114,45811,13611,25512,785.1112,820.6812,856.3412,892.1012,927.96
Accounts Payable (%)
Capital Expenditure -1,367-1,702-1,374-1,379-1,734-1,494.36-1,498.52-1,502.68-1,506.86-1,511.06
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 20.91
Beta 0.694
Diluted Shares Outstanding 865.90
Cost of Debt
Tax Rate -8.83
After-tax Cost of Debt 1.13%
Risk-Free Rate
Market Risk Premium
Cost of Equity 7.934
Total Debt 35,477
Total Equity 18,105.97
Total Capital 53,582.97
Debt Weighting 66.21
Equity Weighting 33.79
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 131,537136,866139,537132,509132,703133,072.12133,442.27133,813.45134,185.66134,558.90
EBITDA 8,3617,2693,3095,4546,3756,110.346,127.336,144.386,161.476,178.61
EBIT 6,5915,2311,3823,4814,3854,192.984,204.644,216.334,228.064,239.82
Tax Rate 15.92%12.04%38.63%33.43%-8.83%18.24%18.24%18.24%18.24%18.24%
EBIAT 5,541.964,601.25848.172,317.184,772.333,428.323,437.863,447.423,457.013,466.62
Depreciation 1,7702,0381,9271,9731,9901,917.361,922.691,928.041,933.401,938.78
Accounts Receivable --653941,469646-1,222-17.35-17.40-17.45-17.50
Inventories -232-1181,292-194-513.79-24.66-24.73-24.80-24.87
Accounts Payable -775117-3,3221191,530.1135.5635.6635.7635.86
Capital Expenditure -1,367-1,702-1,374-1,379-1,734-1,494.36-1,498.52-1,502.68-1,506.86-1,511.06
UFCF 5,944.965,291.251,494.172,350.185,599.343,645.643,855.583,866.303,877.063,887.84
WACC
PV UFCF 3,524.753,604.103,494.273,387.793,284.55
SUM PV UFCF 17,295.45

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 3.43
Free cash flow (t + 1) 3,965.60
Terminal Value 277,314.62
Present Value of Terminal Value 234,282.66

Intrinsic Value

Enterprise Value 251,578.11
Net Debt 34,119
Equity Value 217,459.11
Shares Outstanding 865.90
Equity Value Per Share 251.14